Tune in to TLC on Thursday, July 11th at 9 est / 8 central to see Dr. Sandra Lee, otherwise known as “Dr. Pimple Popper” utilize Sensus Healthcare’s Superficial Radio Therapy (SRT) to treat one of her patients after keloid removal! Superficial Radio Therapy is giving countless keloid sufferers new hope and new confidence. The […]
Blog
Sensus Healthcare to Present at the Raymond James Inaugural Life Sciences and MedTech Conference
BOCA RATON, Fla., June 10, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today that Joe Sardano, CEO of the Company, will present a corporate overview at the Raymond James Inaugural Life Sciences and MedTech Conference on Wednesday, June […]
Sensus Healthcare to Present at the 20th Annual B. Riley FBR Investor Conference
BOCA RATON, Fla., May 15, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today that Joe Sardano, CEO of the Company, will present a corporate overview at the 20th Annual B. Riley FBR Investor Conference on Thursday, May 23 […]
Cancer Near Eye Treated by SRT
Dr. Kevin Schewe, radiation oncologist and medical director at Alliance Cancer Care Colorado, utilized Sensus Healthcare’s SRT to treat an elderly patient with stage 1 basal cell carcinoma cancer near the eye. Without the help of the SRT, this would have possibly caused the patient immobility of the eyelid. Check out the amazing results! To […]
NBC 9News Features Sensus Healthcare’s SRT
05/10/2019 Watch as Dr. Kevin Schewe, radiation oncologist and medical director at Alliance Cancer Care Colorado, speaks about Sensus Healthcare’s SRT and the amazing effects it has on treating non-melanoma skin cancer. “There are 5.4 million new basal cell and squamous cell skin cancers per year in the United States, developing in 3.3 million people”, […]
Sensus Healthcare Reports First Quarter 2019 Financial Results
– Premier, Inc. adds SRT to its group purchasing contracts – Ships second Sculptura™ system to Rabin Medical Center in Israel – Reaffirms expectations for double-digit full-year revenue growth – Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., May 9, 2019 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company […]
Sensus Healthcare Awarded Brachytherapy Products Agreement with Premier
BOCA RATON, Fla., May 8, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in novel radiation oncology technologies and solutions, has been awarded a group purchasing agreement for Brachytherapy Products with Premier. Effective August 1, 2019, the new agreement allows Premier members, at their discretion, to take advantage of special pricing […]
Sensus Healthcare to Host First Quarter 2019 Financial Results and Business Update Conference Call on May 9, 2019
BOCA RATON, Fla., April 25, 2019 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, May 9, 2019 at 4:30 p.m. Eastern time to discuss the financial results for the first quarter […]
Sensus Healthcare Signs R&D Agreement to Collaborate with Perelman School of Medicine at the University of Pennsylvania on World’s First Sculptura™ Intraoperative Radiotherapy System
Sculptura™ Provides Single Treatment During Surgery for Cancer Patients BOCA RATON, Fla., April 24, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in novel radiation oncology technologies and solutions, today announced that the Company has signed a research and development agreement with the Perelman School of Medicine at the University of […]
Five-Year Retrospective Study Shows 98.9 Percent Cure Rate for Non-Melanoma Skin Cancer Patients Treated with Sensus Healthcare’s Superficial Radio Therapy
Sensus’ SRT-100™ Indicates High Cure Rates in Long-Term Retrospective Study BOCA RATON, Fla., April 23, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in non-invasive treatments for both oncological and non-oncological conditions, announced today topline results from a five-year retrospective study of non-melanoma skin cancer (NMSC) patients treated with Superficial Radio […]
Sensus Healthcare Mentioned in SFBJ’s Business of Medicine: ‘It’s an exciting time for the life sciences in Florida’
One of the reasons why Florida is one of the leaders in clinical trial providers is because of the population of this state. The disease population, the elderly, but also healthy volunteers. Florida is No. 2 in the nation for clinical trial providers. Another area of expertise in the South Florida region is RNA technology […]
Sensus Healthcare to Present at the 31st Annual ROTH Conference
BOCA RATON, Fla., March 13, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today that Joe Sardano, CEO of the Company, will present a corporate overview at the 31st Annual ROTH Conference on Tuesday, March 19 at 3:30 p.m. […]
Sensus Healthcare Launches SRT University, an Online Portal to Support Physicians
New Online Portal System to Offer Training and Education Related to SRT Devices and Technology BOCA RATON, Fla., March 12, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today the launch of SRT University, an online portal to support […]
Technology Networks: Superficial Radio Therapy: A non-surgical Treatment for Non-melanoma Skin Cancers
Skin cancer can be broadly split in to two types: melanoma and non-melanoma. The most common non-melanomas include basal cell carcinoma and squamous cell carcinoma, for which the main treatment is surgery. However, other non-surgical options are emerging, including superficial radiation therapy (SRT), a unique type of photon radiotherapy. To learn more about SRT we […]
Thrive Global – The Future of Healthcare: “Using painless, low-dose radiation that only goes skin deep to destroy cancer cells — without damaging health tissue” with Joseph C. Sardano, CEO of Sensus Healthcare, Inc.
As a part of my series about “The Future of Healthcare” I had the pleasure of interviewing Joseph C. Sardano, Chief Executive Officer, Sensus Healthcare Inc. A recognized leader in the healthcare industry, Joe Sardano has spent more than 30 years in management and marketing. He has a successful history of introducing and commercializing new […]
Sensus Healthcare Appoints Dr. Ziv Karni as Chief Scientific Officer
Medical Laser Pioneer and Veteran Entrepreneur Brings Over 30 Years of Experience to Company BOCA RATON, Fla., Feb. 28, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today that the Company has appointed Dr. Ziv Karni to the role […]
All about Keloid Scar Removal
Keloid scar removal is often an elusive task. This leaves many people living with unsightly scarring when the fact is they don’t need to! Here’s what you need to know about treating keloids most effectively. What Are Keloids? If you haven’t suffered from them, chances are that you have never heard of keloids. However, keloids […]
U.S. FDA Grants Market Clearance to Sensus Healthcare’s New Sculptura™ Radiation Oncology System
A Single Treatment during Surgery, Sculptura™ Eliminates Weeks of Post-Operative Radiation for Cancer Patients BOCA RATON, Fla., Feb. 26, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today that the U.S. Food and Drug Administration (FDA) has granted market […]
Sensus Healthcare Fourth Quarter Financial Results Feature Record Revenue and Continued Double-digit Growth
Shipped 27 systems during the quarter including 15 SRT-100 Vision™ systems Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Feb. 14, 2019 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces financial results […]
Leading Dermatologists Develop Consensus Guidelines for the Use of Superficial Radio Therapy to Treat Non-Melanoma Skin Cancers and Keloids
Published in The Journal of Clinical and Aesthetic Dermatology, Consensus was Reached that SRT is Safe, and Effective in Treating SCC and BCC and Should be Considered as the First-Line Form of Radiation Treatment. BOCA RATON, Fla., Feb. 14, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment […]